Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,194.00    16.00 (0.73%)
Bid:
2,190.00
Ask:
2,198.00
Spread: 8.00 (0.365%)
Market Cap: £1.46b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Pre Close Trading Update

9 Jan 2007 07:00

Genus PLC09 January 2007 For Immediate Release 9 January 2007 GENUS plc ('Genus' or 'the Company') Pre-Close Trading Update Genus plc, the world's leading animal genetics company, is pleased to announce that trading in the six month period ended 31 December 2006 has been in line with the Board's expectations and, as already reported, the synergies and cost savings achieved through the acquisition of Sygen International plc continue in line with our enhanced targets of both quantum and timing. The Board currently anticipates that market conditions will be broadly unchanged for the second half of the financial year. In progressing towards the announced move from AIM to the Official List, the Company is preparing its historical accounts for the fifteen months to 30 June 2006 under International Financial Reporting Standards ("IFRS"). This work is substantially complete and is in the process of being audited. The impact of adopting IFRS on these accounts compared with the current accounting practice ("UK GAAP") is expected to be material in relation to the Agricultural Assets Standard, IAS 41. As anticipated, the impact of this Standard will be to increase the Company's net assets significantly as at 30 June 2006 by fair valuing the Company's biological assets principally associated with the Company's studs and nucleus herds. The impact of other differences is expected to be immaterial. A transition document which will illustrate the reconciling differences between UK GAAP and IFRS will be available on the Company's website prior to the intended announcement on 13 March 2007 of the Interim Results for the six months ended 31 December 2006. After considering the complexity and additional cost of auditing the interim results, required only for listing purposes, the Board has decided to conduct the move to the Official List after the audited results for the year ending 30 June 2007 have been published. In pursuit of the Board's strategy to improve liquidity in Genus shares and to reduce the administration costs of servicing small shareholders, the Company carried out a further voluntary share buyback programme in December 2006. As a result, we are pleased to announce that a total of 836,469 shares (1.5% of issued share capital) were placed with institutions under this programme. For further information please contact: Genus plc Tel: 01256 347 100 Richard Wood, Chief ExecutiveDavid Timmins, Finance Director Buchanan Communications Tel: 020 7466 5000 Charles RylandSuzanne BrocksSimon Potter This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Jun 20268:28 amRNSHolding(s) in Company
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.